Labs Partner with Pharma Companies to Develop New CDx Tests
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
In a surprise move, the e-retail giant announced it will close down its Amazon Care Primary Health Services for employees at the end of 2022.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.
Some of the lab industry’s biggest players are teaming up to develop new monkeypox diagnostics in response to the current outbreak.
A hostile government policy has done little to slow consolidation of independent medical practices and hospitals.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
A hot trend in capital raising for the healthcare and life sciences industries only two years ago, SPAC deals have petered out, but are far from dead.